Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 10/2001

01-10-2001 | ARTICLE

New aspects of the insulin resistance syndrome: impact on haematological parameters

Authors: M. Barbieri, E. Ragno, E. Benvenuti, G. A. Zito, A. Corsi, L. Ferrucci, G. Paolisso

Published in: Diabetologia | Issue 10/2001

Login to get access
Metadata
Title
New aspects of the insulin resistance syndrome: impact on haematological parameters
Authors
M. Barbieri
E. Ragno
E. Benvenuti
G. A. Zito
A. Corsi
L. Ferrucci
G. Paolisso
Publication date
01-10-2001
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2001
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250100634

Other articles of this Issue 10/2001

Diabetologia 10/2001 Go to the issue

Letters

Mutations of the peroxisome proliferator-activated receptor γ (PPARγ) gene in a Japanese population : the Pro12Ala mutation in PPARγ2 is associated with lower concentrations of serum total and non-HDL cholesterol

Article

The content of glycogen phosphorylase and glycogen in preparations of sarcoplasmic reticulum–glycogenolytic complex is enhanced in diabetic rat skeletal muscle

Article

Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey

Article

SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes

Article

Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media

Article

A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits